Business
PharmaCielo's Very First Commercial CBD Export from Colombia Lands in Europe
PharmaCielo's Very First Commercial CBD Export from Colombia Lands in Europe Canad...
About this update from Pharmacielo Ltd.
[{"type":"text","content":"\n\n\n\nPharmaCielo's Very First Commercial CBD Export from Colombia Lands in Europe\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\n\nCanada NewsWire\nTORONTO and CHAM, Switzerland, Aug. 19, 2019\n\n\n\nCommercial shipment delivers CBD isolate to Switzerland-based Creso Pharma Company executed overseas commercial delivery weeks after securing the first commercial exporting permit from Colombian government announced July 25 Delivery demonstrates potential synergies between the two companies TORONTO and CHAM, Switzerland, Aug. 19, 2019 /CNW/ - PharmaCielo Ltd. (\"PharmaCielo\" or the \"Company\") (TSXV:PCLO, OTC:PHCEF), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade cannabis oil, PharmaCielo Colombia Holdings S.A.S., confirmed today it successfully completed the first commercial export of CBD isolate to Europe. \n\n \n \n\n \nThe inaugural shipment of the high quality CBD isolate, a key ingredient in various cannabis derived therapeutic, nutraceutical, topicals and lifestyle products, was delivered to the Swiss headquarters of Creso Pharma, a global pharmaceutical with expertise in cannabis- and hemp-derived products for human and veterinarian use. This comes on the heels of the Colombian government granting the first commercial CBD isolate exporting permit to PharmaCielo, as announced on July 25, 2019.\n\"This inaugural shipment is symbolic on many levels. PharmaCielo is the first medicinal cannabis company to commercially export cannabis derived isolates from Colombia to Switzerland - the global capital of the pharma industry. Particularly pleasing is the fact that the first batch we ever exported went to Creso Pharma, our trusted partner soon to be part of our Company,\" said David Attard, CEO at PharmaCielo Ltd. \"PharmaCielo's ability to successfully navigate the complex exporting process gives us a tremendous advantage in the market, as required for continuing exports from Colombia of cannabis derived extracts and crystals. It also demonstrates the synergies between the Company and Creso Pharma that will be realized and aug...